It will be of high interest to determine which isoform of WNT5A exerts oncogenic functions in melanomas and gastric and pancreatic carcinomas [11-16], and monitoring the respective expression levels of WNT5A-L and WNT5A-S may be a useful cancer biomarker. This evidence concerns the gene WNT5A and exocrine pancreatic carcinoma.